COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake

Hum Vaccin Immunother. 2022 Nov 30;18(5):2062972. doi: 10.1080/21645515.2022.2062972. Epub 2022 Apr 18.

Abstract

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic during the fall of 2019 led to the rapid development of vaccines aimed at curbing viral infection, spread, and its potential eradication. A recent trend is an overall increase in vaccine hesitancy, leading to the World Health Organization citing this as a problem which needs to be addressed. With the development and approval of vaccines for COVID-19, this trend has quickened, leading to potential negative ramifications in the ability controlling COVID-19 spread. Here we describe reported examples in overall vaccine hesitancy prior to the emergence of COVID-19, as well as summarizing recent reports on vaccine hesitancy related to COVID-19 vaccines. Gaining a better understanding of the reasons individuals have, as well as potential methods for decreasing hesitancy in the future, will hopefully lead to a greater percentage of vaccinated individuals and aid in ending the current pandemic.

Keywords: COVID-19; SARS-CoV-2; hesitancy; pandemic; vaccine.

Publication types

  • Review

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination
  • Vaccination Hesitancy
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.